| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | ||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2022 | Apr 20, 2022 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $11.04 | 5,000 | $55,200 | -0 |
| Feb 15, 2022 | Feb 16, 2022 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $18.5 | 5,000 | $92,500 | -0 |
| Nov 15, 2021 | Nov 17, 2021 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $12.27 | 5,000 | $61,350 | -0 |
| Sep 15, 2021 | Sep 17, 2021 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $15.06 | 5,000 | $75,300 | -0 |
| Sep 10, 2021 | Sep 14, 2021 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $15.09 | 74,000 | $1M | -0 |
| Jul 15, 2021 | Jul 19, 2021 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $15.69 | 5,000 | $78,450 | -62.50% |
| May 24, 2021 | May 26, 2021 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $13.9 | 6,667 | $92,671 | -68.97% |
| May 10, 2021 | May 12, 2021 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $12.7 | 7,000 | $88,900 | -70.00% |
| Aug 21, 2018 | Aug 22, 2018 | Abercrombie George B SVP Chief Comm. Officer | Sell | Innoviva, Inc. | INVA | $14.11 | 8,000 | $112,840 | -2.73% |
| May 21, 2018 | May 22, 2018 | Abercrombie George B SVP Chief Comm. Officer | Sell | Innoviva, Inc. | INVA | $14.4 | 8,000 | $115,202 | -2.60% |
| Feb 21, 2018 | Feb 22, 2018 | Abercrombie George B SVP Chief Comm. Officer | Sell | Innoviva, Inc. | INVA | $16.51 | 8,000 | $132,100 | -3.29% |
| Nov 21, 2017 | Nov 22, 2017 | Abercrombie George B SVP Chief Comm. Officer | Sell | Innoviva, Inc. | INVA | $13.26 | 5,215 | $69,145 | -1.98% |
| Nov 12, 2013 | Nov 13, 2013 | Abercrombie George B Dir | Buy | Biocryst Pharmaceuticals Inc | BCRX | $6.19 | 3,000 | $18,570 | +33.33% |